Please assess the completion status of the following clinical trial:

Trial Title: Multimodal Treatment Strategy for Cancer Cachexia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Are referred to the Cachexia Clinic with involuntary weight loss of \>5% of their premorbid weight within the previous 6 months.~2. Are 18 years of age or older~3. Have a Karnofsky performance score of 60 or higher.~4. Can maintain oral food intake during the study~5. Can understand the study procedures and can sign an informed consent form.~6. Are not currently taking melatonin.~7. Are taking megestrol acetate and continue to lose weight despite at least 2 weeks of therapy.~8. Have a calculated creatinine clearance of \>/= 60 cc/min.~Exclusion Criteria:~1. Have dementia or delirium (as determined by the palliative care specialist) at study entry.~2. Are pregnant~3. Have been taking corticosteroids for longer than 48 hours.~4. Have pulmonary edema, ascites or pitting edema on clinical examination.~5. Are unable to walk.~6. Have a history of serious adverse gastrointestinal events (i.e., bleeding or perforation),history of a coagulopathy or current anti-coagulant use.~7. Have an ALT/AST\>3x upper limit of normal.~8. Patients on methotrexate.~9. Patients taking melatonin receptor agonists (such as Rozerem® \[ramelteon\]).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Multimodal Treatment Strategy (Type: EXPERIMENTAL): Exercise Program + Pharmacologic Intervention (Melatonin + Atenolol + Ibuprofen) + Nutritional Supplementation (Juven) - Resistance training sessions twice weekly using Thera-bands. Walking or running for 3-4 minutes at 70-80% of maximum predicted heart rate. Melatonin 20 mg by mouth (PO) Daily. 90 calories of Juven, twice a day.

Based on this trial design, predict the completion outcome and termination type (if applicable).